Cancer’s dangerous renovations to our chromosomes revealed
Cancer remodels the architecture of our chromosomes so the disease can take hold and spread, new research reveals.
Read more
Cancer
Racial Disparities in Treatment for Common Lung Cancer Persist Despite Gains
African American patients with lung cancer are still less likely to receive the most effective treatment for a common type of early stage lung cancer.
Read moreGreater prostate cancer incidence; mortality among Black men linked to genetic alterations
Bottom Line: Prostate cancer tumors from African American men had higher frequencies of certain genetic alterations that may be associated
Read morePenn Medicine Researchers Receive $5.4 million Grant to Find Genetic Drivers of Testicular Cancer
A team of researchers led by Katherine L. Nathanson, MD, deputy director of the Abramson Cancer Center and the Pearl Basser Professor for BRCA-Related Research in the Perelman School of Medicine at the University of Pennsylvania, was recently awarded $5.4 million over five years from the National Institutes of Health to continue the long-standing genomics work of the TEsticular CAncer Consortium.
Read more
DERMATOLOGIST SAVES SOUTH FLORIDA MAN’S LIFE WITH EARLY DIAGNOSIS OF LUNG CANCER
The American Academy of Dermatology named board-certified dermatologist Brittany Smirnov, DO, FAAD, a Patient Care Hero for her role in diagnosing and treating a patient with stage IV metastatic lung cancer.
Read more
Cancer treatment without side effects?
Irvine, Calif., Oct. 27, 2020 – Treating cancer without debilitating side effects has long been the holy grail of oncologists, and researchers at the University of California, Irvine and Switzerland’s Lausanne University Hospital may have found it. Charles Limoli, professor of radiation oncology at UCI, and Marie-Catherine Vozenin, associate professor of radiation oncology at the Swiss facility, used an ultra-high dose rate of radiation therapy to eliminate brain tumors in mice, bypassing key side effects usually caused by cranial irradiation.
Read more‘Fast’ MRI Detects Breast Cancers that 3-D Mammograms May Miss
In a retrospective study of Penn Medicine patients, all of whom had a negative 3-D mammogram within the previous 11 months, abbreviated MRI detected roughly 27 cancers per 1,000 women screened. By comparison, 3-D mammography detects about four to five cancers in 1,000 women screened, on average.
Read more
Activating “Inflammasome” May Improve Cancer’s Response To Immunotherapy And Parp Inhibitors
The inflammasome—a protein signaling network that is activated to rid the body of virus or bacteria-infected cells—may play an important role in triggering an immune response to cancer and causing an existing class of drugs to work better against cancers.
Read moreSIO partners with leading oncology society on integrative cancer care guidelines
Medical societies to develop three evidence-based clinical practice guidelines in 2021
Read moreLow quantity and quality of muscle predicts poor outcomes in colon cancer surgery
Low muscle quality and quantity are both predictive of poor outcomes in colon resection surgery, according to a new study
Read moreResearchers discover proton regulator of essential cancer microRNA
The UNC School of Medicine lab of Qi Zhang, PhD, used nuclear magnetic resonance imagine to discover an RNA-centric mechanism for regulating the creation of a microRNA in response to environmental stimuli
Read more‘Fast’ MRI detects breast cancers that 3-D mammograms may miss
Study of Penn Medicine patients shows abbreviated MRI may be a valuable supplemental screening for women with dense breasts
Read more